Retrovirology

official impact factor 5.24

This article is part of the supplement: 2005 International Meeting of The Institute of Human Virology

Open Access

The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1

Alonso Heredia*, Anthony Amoroso, Charles Davis, Nhut Le, Douty Bamba, Robert Gallo and Robert Redfield

  • * Corresponding author: Alonso Heredia

Retrovirology 2005, 2(Suppl 1):P134 doi:10.1186/1742-4690-2-S1-P134

Accesses  

  • Last 30 days: 18 accesses
  • Last 365 days: 192 accesses
  • All time: 501 accesses